In vitro ganewar asali hanya ce mai mahimmanci don ganowa da kuma kula da cututtuka, kuma yana taka muhimmiyar rawa a cikin dukan tsarin rigakafin cututtuka, ganewar asali, ganowa da jagorancin jiyya.A halin yanzu, kusan kashi biyu bisa uku na shawarwarin likita a duk duniya sun dogara ne akan sakamakon bincike.Tare da saurin haɓaka sabbin fasahohi da haɓaka manufofin inshorar likitanci sannu a hankali a cikin ƙasashe daban-daban, masana'antar bincikar in vitro tana haɓaka cikin saurin ci gaba, kuma ta zama ɗaya daga cikin mafi saurin girma da haɓaka sassa na masana'antar likitanci. .
A shekarar 2023, an maido da ci gaban masana'antar binciken in vitro gaba daya zuwa matsayin da aka riga aka yi fama da shi, kuma ana sa ran girman kasuwar masana'antar binciken in vitro ta kasar Sin zai kai kusan yuan biliyan 200. A rabin farkon shekarar 2023, kamfanonin da aka lissafa galibi a cikin kasuwancin IVD, gabaɗayan haɓakar shekara-shekara a cikin kudaden shiga har yanzu galibi mara kyau ne.Duba rahoton mai zuwa don cikakkun bayanai.
Lokacin aikawa: Agusta-30-2023